This FREE online program will explore how national health and sociopolitical events in 2020 will impact future cancer care delivery in the United States. Convening a group of diverse speakers and panelists, the virtual summit will discuss the influence
of watershed events including the COVID-19 pandemic, post-election landscape, and national conversations of racial inequity on cancer care.
Supported by Adaptive, ADC Therapeutics, AmerisourceBergen, Apobiologix, Astellas, BeiGene, Ltd., BMS, bluebird bio, Boehringer Ingelheim Pharmaceuticals, Inc., Eisai Inc, EMD Serono, Epizyme, EQRx, Exelixis, Foundation Medicine, Inc., GSK, Helsinn, Heron, Incyte Corporation, Janssen Oncology, Kite, a Gilead Company, MorphoSys US, Inc., Regeneron Pharmaceuticals, Inc., QED Therapeutics, Sun Pharma Oncology, and TG Therapeutics. Supported by AstraZeneca through its NCCN Corporate Council Membership. Supported by an independent educational grant from Merck & Co., Inc. This event is sponsored by Lilly Oncology. This activity was made possible by Pharmacyclics, an AbbVie Company.